Similar articles for PMID: 16807460

Year	Number of Results
1989	1
1999	3
2000	1
2001	5
2002	3
2004	3
2005	9
2006	2
2007	4
2008	1
2010	2
2011	1
2012	1
2014	2
2015	1
2016	4
2017	1
2024	0

1

10-year update on chemotherapy for non-small cell lung cancer.

Abratt RP, Hart GJ. Abratt RP, et al. Ann Oncol. 2006 May;17 Suppl 5:v33-36. doi: 10.1093/annonc/mdj947. Ann Oncol. 2006. PMID: 16807460 Free article.

2

[Treatment of the unresectable non small cell lung carcinoma].

Spásová I. Spásová I. Cas Lek Cesk. 2005;144(9):602-12; discussion 612-3. Cas Lek Cesk. 2005. PMID: 16193938 Review. Czech.

3

Efficacy and side effects of cisplatin- and carboplatin-based doublet chemotherapeutic regimens versus non-platinum-based doublet chemotherapeutic regimens as first line treatment of metastatic non-small cell lung carcinoma: a systematic review of randomized controlled trials.

Rajeswaran A, Trojan A, Burnand B, Giannelli M. Rajeswaran A, et al. Lung Cancer. 2008 Jan;59(1):1-11. doi: 10.1016/j.lungcan.2007.07.012. Epub 2007 Aug 27. Lung Cancer. 2008. PMID: 17720276 Review.

4

A meta-analysis of randomized controlled trials comparing carboplatin-based to cisplatin-based chemotherapy in advanced non-small cell lung cancer.

Jiang J, Liang X, Zhou X, Huang R, Chu Z. Jiang J, et al. Lung Cancer. 2007 Sep;57(3):348-58. doi: 10.1016/j.lungcan.2007.03.014. Epub 2007 May 7. Lung Cancer. 2007. PMID: 17485133

5

Platinum-based versus non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a meta-analysis of the published literature.

D'Addario G, Pintilie M, Leighl NB, Feld R, Cerny T, Shepherd FA. D'Addario G, et al. J Clin Oncol. 2005 May 1;23(13):2926-36. doi: 10.1200/JCO.2005.03.045. Epub 2005 Feb 22. J Clin Oncol. 2005. PMID: 15728229

6

First-line chemotherapy for advanced-stage non-small-cell lung cancer: focus on docetaxel.

Ramalingam S. Ramalingam S. Clin Lung Cancer. 2005 Dec;7 Suppl 3:S77-82. doi: 10.3816/clc.2005.s.014. Clin Lung Cancer. 2005. PMID: 16384540 Review.

7

Taxanes as first-line therapy for advanced non-small cell lung cancer: a systematic review and practice guideline.

Chu Q, Vincent M, Logan D, Mackay JA, Evans WK; Lung Cancer Disease Site Group of Cancer Care Ontario's Program in Evidence-based Care. Chu Q, et al. Lung Cancer. 2005 Dec;50(3):355-74. doi: 10.1016/j.lungcan.2005.06.010. Epub 2005 Aug 31. Lung Cancer. 2005. PMID: 16139391 Review.

8

Chemotherapy for advanced non-small cell lung cancer: standards.

Manegold C. Manegold C. Lung Cancer. 2001 Dec;34 Suppl 2:S165-70. doi: 10.1016/s0169-5002(01)00363-4. Lung Cancer. 2001. PMID: 11720760 Review.

9

First-line treatment for advanced non-small-cell lung cancer.

Laskin JJ, Sandler AB. Laskin JJ, et al. Oncology (Williston Park). 2005 Nov;19(13):1671-6; discussion 1678-80. Oncology (Williston Park). 2005. PMID: 16425521 Review.

10

[Gemcitabine in the first line therapy of advanced and metastatic non-small-cell lung carcinoma (NSCLC): review of the results of phase III studies].

Langer F, Helsberg K, Schütte WH, Leschinger MI. Langer F, et al. Onkologie. 2005 Mar;28 Suppl 1:1-28. doi: 10.1159/000084364. Epub 2005 Mar 30. Onkologie. 2005. PMID: 15802886 Review. German.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

42 results

Results by year